Literature DB >> 32223728

Diosmetin Induces Apoptosis by Downregulating AKT Phosphorylation via P53 Activation in Human Renal Carcinoma ACHN Cells.

Mingning Qiu1,2, Jie Liu1,2, Yongxia Su1,2, Rong Guo2, Baoyu Zhao2, Jianjun Liu1.   

Abstract

BACKGROUND: Diosmetin (DIOS) is the aglycone of the flavonoid glycoside, diosmin, derived naturally from the leaves of the legume, Olea europaea, and Acacia farnesiana. It has potent anticancer activity against multiple forms of cancers. However, the role of DIOS in renal carcinoma and its mechanism of action remain unclear.
OBJECTIVE: The purpose of this study is to investigate the effect of DIOS on cell viability and apoptosis in renal carcinoma cells and explore the possible mechanism of action.
METHODS: Cell viability, cytotoxicity, caspase activity, apoptosis, and expression of apoptotic related proteins were analyzed in renal carcinoma ACHN cells.
RESULTS: The results showed that DIOS inhibited the cell viability, and induced cytotoxicity and apoptosis in ACHN cells. Furthermore, DIOS increased expression of p53 mRNA and proteins, and downregulated phosphorylation of the phosphoinositide 3-kinase and protein B kinase (PI3K/AKT). In addition, it was observed that the anticancer effect of DIOS was significantly enhanced by the p53 activator, but inhibited by the p53 inhibitor.
CONCLUSION: Our data suggested that DIOS induced apoptosis in renal carcinoma ACHN cells by reducing AKT phosphorylation through p53 upregulation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  ACHN cells; AKT phosphorylation; Diosmetin; apoptosis; p53; renal carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32223728     DOI: 10.2174/0929866527666200330172646

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  3 in total

1.  Exploration of the Danggui Buxue Decoction Mechanism Regulating the Balance of ESR and AR in the TP53-AKT Signaling Pathway in the Prevention and Treatment of POF.

Authors:  Huaiquan Liu; Hong Yang; Zhong Qin; Yunzhi Chen; Haiyang Yu; Wen Li; Xing Zhu; Jingwen Cai; Jing Chen; Mengzhi Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-30       Impact factor: 2.629

2.  Interference with megalin expression/endocytic function by montelukast mitigates gentamicin nephrotoxicity: Downregulation of ClC-5 expression.

Authors:  Amany A Azouz; Dina A Hanna; Ali A Abo-Saif; Basim Anwar Shehata Messiha
Journal:  Saudi Pharm J       Date:  2022-01-04       Impact factor: 4.562

3.  Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.

Authors:  Ning Wang; Rongjiang Wang; Jianer Tang; Jianguo Gao; Zhihai Fang; Meng Zhang; Xufeng Shen; Lingqun Lu; Yu Chen
Journal:  Contrast Media Mol Imaging       Date:  2022-09-15       Impact factor: 3.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.